| Literature DB >> 35864140 |
D Seppelt1, M L Kromrey2, T Ittermann3, C Kolb4, A Haubold4, N Kampfrath5, D Fedders4, P Heiss6, S Hoberück7, R T Hoffmann4, J P Kühn4.
Abstract
To evaluate the suitability of volume index measurement (VI) by either ultrasound (US) or computed tomography (CT) for the assessment of liver volume. Fifty-nine patients, 21 women, with a mean age of 66.8 ± 12.6 years underwent US of the liver followed immediately by abdominal CT. In US and CT imaging dorsoventral, mediolateral and craniocaudal liver diameters in their maximum extensions were assessed by two observers. VI was calculated by multiplication of the diameters divided by a constant (3.6). The liver volume determined by a manual segmentation in CT ("true liver volume") served as gold standard. True liver volume and calculated VI determined by US and CT were compared using Bland-Altman analysis. Mean differences of VI between observers were - 34.7% (- 90.1%; 20.7%) for the US-based and 1.1% (- 16.1%; 18.2%) for the CT-based technique, respectively. Liver volumes determined by semi-automated segmentation, US-based VI and CT-based VI, were as follows: 1.500 ± 347cm3; 863 ± 371cm3; 1.509 ± 432cm3. Results showed a great discrepancy between US-based VI and true liver volume with a mean bias of 58.3 ± 66.9%, and high agreement between CT-based VI and true liver volume with a low mean difference of 4.4 ± 28.3%. Volume index based on CT diameters is a reliable, fast and simple approach for estimating liver volume and can therefore be recommended for clinical practice. The usage of US-based volume index for assessment of liver volume should not be used due to its low accuracy of US in measurement of liver diameters.Entities:
Mesh:
Year: 2022 PMID: 35864140 PMCID: PMC9304384 DOI: 10.1038/s41598-022-16736-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1Example of a representative measurement of diameters in ultrasonography. Images were taken during the measurement of maximum diameters in (A) mediolateral (USmaxML), (B) craniocaudal (USmaxCC) and (C) dorsoventral direction (USmaxDV).
Figure 2Representative measurement of maximum diameters in CT. Measurements were taken in the three standard dimensions (A) mediolateral (CTmaxML) + craniocaudal (CTmaxCC) and (B) dorsoventral (CTmaxDV).
Figure 3Refined contour of the liver after semi-automatic extraction of the liver parenchyma from abdominal CT-image in Syngo.Via and excluding the hepatic and portal vein (A) 3D model of the liver after post-processed liver shape (B).
Figure 4Bland–Altman correlation between the diameters measured in maximum extension in ultrasound and CT (A) in mediolateral, (B) dorsoventral and (C) craniocaudal orientation with showing the smallest difference in mediolateral extension.
Mean and standard deviations of maximum diameters measured in ultrasound, computed tomography and true liver volume extracted from manual liver segmentation.
| Ultrasonography | Computed tomography | True liver volume | |
|---|---|---|---|
| maxML(cm) | 18.2 ± 3.4 | 18.2 ± 2.4 | |
| maxDV(cm) | 13.9 ± 3.4 | 17.9 ± 2.7 | |
| maxCC(cm) | 12.3 ± 2.9 | 16.0 ± 2.1 | |
| Mean liver volume (cm3) | 863.4 ± 371.8 | 1454.7 ± 414.4 | 1500 ± 347.8 |
Intraclass correlation coefficients for inter-rater variability.
| Volume index | Craniocaudal diameter | Dorsoventral diameter | Mediolateral diameter | |
|---|---|---|---|---|
| CT | 0.94 | 0.88 | 0.96 | 0.86 |
| US | 0.29 | 0.48 | 0.76 | 0.72 |
Figure 5Linear correlation and Bland–Altman correlation between calculated VI from CT and true liver volume.
Figure 6Linear correlation and Bland–Altman correlation between calculated VI from US and true liver volume.
Patients characteristics and laboratory data.
| Patients characteristics / Laboratory data | Mean ± standard deviation |
|---|---|
| Age | 66.8 ± 12.6 years |
| Height | 1.71 ± 0.1 m |
| Weight | 79.8 ± 17.6 years |
| Body mass index | 26.9 ± 5 kg/m2 |
| thickness of subcutaneous layer from ventral | 17.0 ± 8.9 cm |
| thickness of subcutaneous layer from lateral | 12.7 ± 8.1 cm |
| ALAT | 0.44 ± 0.25 µmol/(s*L) |
| ASAT | 0.55 ± 0.54 µmol/(s*L) |
| GGT | 1.08 ± 2.04 µmol/(s*L) |
| Bilirubin | 9.01 ± 4.93 µmol/L |
| Platelet count | 227.33 ± 88.96 |
| Fib-4 score | 2.11 ± 1.6 (N = 23 < 1.45, N = 7 > 3.75 and N = 24 in between) |